Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Read More…
Industry, Sector and Symbol
Industry Food stores
Sub-IndustrySpecialty Stores
SectorRetail/Wholesale
Phone201-868-5959
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.11 billion
Profitability
Miscellaneous
Employees5,136
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Vitamin Shoppe (NYSE:VSI) Frequently Asked Questions
What is Vitamin Shoppe's stock symbol?
Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."
How were Vitamin Shoppe's earnings last quarter?
Vitamin Shoppe Inc (NYSE:VSI) released its quarterly earnings results on Thursday, August, 8th. The specialty retailer reported $0.20 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.12 by $0.08. The specialty retailer earned $270.88 million during the quarter, compared to analysts' expectations of $278.60 million. Vitamin Shoppe had a positive return on equity of 3.34% and a negative net margin of 0.66%. View Vitamin Shoppe's Earnings History.
When is Vitamin Shoppe's next earnings date?
What price target have analysts set for VSI?
2 brokerages have issued twelve-month target prices for Vitamin Shoppe's stock. Their forecasts range from $4.00 to $4.00. On average, they expect Vitamin Shoppe's stock price to reach $4.00 in the next twelve months. This suggests that the stock has a possible downside of 38.7%. View Analyst Price Targets for Vitamin Shoppe.
What is the consensus analysts' recommendation for Vitamin Shoppe?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitamin Shoppe in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Vitamin Shoppe.
Has Vitamin Shoppe been receiving favorable news coverage?
News stories about VSI stock have trended negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Vitamin Shoppe earned a news sentiment score of -2.6 on InfoTrie's scale. They also gave news headlines about the specialty retailer a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Vitamin Shoppe.
Are investors shorting Vitamin Shoppe?
Vitamin Shoppe saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 3,310,000 shares, a drop of 23.4% from the August 30th total of 4,320,000 shares. Based on an average daily trading volume, of 628,000 shares, the days-to-cover ratio is currently 5.3 days. Approximately 16.8% of the company's stock are sold short. View Vitamin Shoppe's Current Options Chain.
Who are some of Vitamin Shoppe's key competitors?
What other stocks do shareholders of Vitamin Shoppe own?
Who are Vitamin Shoppe's key executives?
Vitamin Shoppe's management team includes the folowing people:
- Mr. David M. Kastin, Sr. VP, Gen. Counsel & Corp. Sec. (Age 51)
- Ms. Sharon M. Leite, CEO & Director (Age 56)
- Mr. Charles D. Knight, Interim CFO, Sr. VP & Chief Accounting Officer (Age 55)
- Mr. Andrew Laudato, CTO & Exec. VP (Age 52)
- Mr. David Morrison, VP of Scientific & Regulatory Affairs
Who are Vitamin Shoppe's major shareholders?
Vitamin Shoppe's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Alpha Windward LLC (0.27%) and State of Alaska Department of Revenue (0.05%). Company insiders that own Vitamin Shoppe stock include Alex Smith, Guillermo Marmol, Shah Capital Management, Sharon M Leite and Vintage Capital Management Llc. View Institutional Ownership Trends for Vitamin Shoppe.
Which major investors are selling Vitamin Shoppe stock?
Which major investors are buying Vitamin Shoppe stock?
VSI stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have bought Vitamin Shoppe stock in the last two years include Alex Smith, Guillermo Marmol, Shah Capital Management, Sharon M Leite and Vintage Capital Management Llc. View Insider Buying and Selling for Vitamin Shoppe.
How do I buy shares of Vitamin Shoppe?
Shares of VSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Vitamin Shoppe's stock price today?
One share of VSI stock can currently be purchased for approximately $6.52.
How big of a company is Vitamin Shoppe?
Vitamin Shoppe has a market capitalization of $156.87 million and generates $1.11 billion in revenue each year. The specialty retailer earns $-3,750,000.00 in net income (profit) each year or $0.26 on an earnings per share basis. Vitamin Shoppe employs 5,136 workers across the globe.View Additional Information About Vitamin Shoppe.
What is Vitamin Shoppe's official website?
How can I contact Vitamin Shoppe?
Vitamin Shoppe's mailing address is 300 HARMON MEADOW BLVD., SECAUCUS NJ, 07094. The specialty retailer can be reached via phone at 201-868-5959 or via email at [email protected]
MarketBeat Community Rating for Vitamin Shoppe (NYSE VSI)
MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe VSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
